v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2025
Mar. 31, 2025
Current assets    
Cash and cash equivalents $ 5,853,493 $ 5,501,261
Australian Research and Development Tax Incentive  receivable 218,314 0
Prepaid expenses and other current assets 182,072 448,539
Total current assets 6,253,879 5,949,800
Property and equipment, net 513,992 676,220
Operating lease right-of-use asset 456,496 601,846
Patents, net 275 550
Restricted cash 98,448 97,813
Deposits 0 33,305
Total assets 7,323,090 7,359,534
Current liabilities    
Accounts payable 570,792 534,524
Due to related parties 248,454 579,565
Operating lease liability, current portion 324,656 313,033
Other current liabilities 261,095 472,164
Total current liabilities 1,404,997 1,899,286
Operating lease liability, less current portion 172,116 336,718
Total liabilities 1,577,113 2,236,004
Stockholders’ Equity    
Common stock, par value $0.001 per share; 6,000,000 shares authorized as of September 30, 2025 and March 31, 2025; 761,318 shares issued and outstanding as of September 30, 2025 and 258,531 shares issued and outstanding at March 31, 2025. 761 259
Additional paid-in capital 176,975,368 173,095,221
Accumulated other comprehensive loss (26,377) (17,133)
Accumulated deficit (171,203,775) (167,954,817)
Total stockholders’ equity 5,745,977 5,123,530
Total liabilities and stockholders’ equity $ 7,323,090 $ 7,359,534

Source

10-Q PDF
XBRL